title: The multiple site binding of carboxypeptidase Y inhibitor (IC) to the cognate proteinase. Implications for the biological roles of the phosphatidylethanolamine-binding protein.
abstract: The serine carboxypeptidase inhibitor in the cytoplasm of Saccharomyces cerevisiae, IC, specifically inhibits vacuolar carboxypeptidase Y (CPY) and belongs to a functionally unknown family of phosphatidylethanolamine-binding proteins (PEBPs). In the presence of 1 M guanidine hydrochloride, a CPY-IC complex is formed and is almost fully activated. The reactivities of phenylmethylsulfonyl fluoride, p-chloromercuribenzoic acid, and diisopropyl fluorophosphate toward the complex are considerably increased in 1 M guanidine hydrochloride, indicating that IC contains a binding site other than its inhibitory reactive site. IC is able to form the complex with diisopropyl fluorophosphate-modified CPY. Tryptic digestion of the complex indicates that two fragments from IC are involved in complex formation with CPY. These findings demonstrate the multiple site binding of IC with CPY. Considering the fact that mouse PEBP has recently been identified as a novel thrombin inhibitor, the binding that characterizes the CPY-IC complex could be a common feature of PEBPs.
authors.affiliation: Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan. mima@kais.kyoto-u.ac.jp
authors.forename: Joji
authors.initials: J
authors.lastname: Mima
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Narita
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Chiba
authors.forename: Rikimaru
authors.initials: R
authors.lastname: Hayashi
mesh_terms: D000595:Amino Acid Sequence; D000727:Androgen-Binding Protein; D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000378:metabolism; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors* / Q000737:chemistry; D002352:Carrier Proteins / Q000737:chemistry; D002384:Catalysis; D043402:Cathepsin A; D002850:Chromatography, Gel; D003432:Cross-Linking Reagents / Q000494:pharmacology; D003545:Cysteine / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D019791:Guanidine / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D008969:Molecular Sequence Data; D010277:Parasympathomimetics / Q000494:pharmacology; D010714:Phosphatidylethanolamines / Q000378:metabolism; D049294:Phospholipid Transfer Proteins; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D012694:Serine / Q000737:chemistry; D013997:Time Factors; D014357:Trypsin / Q000494:pharmacology
chemical_list: D000727:Androgen-Binding Protein; D002352:Carrier Proteins; D003432:Cross-Linking Reagents; D010277:Parasympathomimetics; D010714:Phosphatidylethanolamines; D049294:Phospholipid Transfer Proteins; D012694:Serine; D002268:Carboxypeptidases; D043402:Cathepsin A; D014357:Trypsin; D019791:Guanidine; D003545:Cysteine